Fellowship · Brooklyn, NY
Sponsored by SUNY Downstate Health Sciences University
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.
Lancet (London, England) · 2021 · 476 citations · Ellen Ginzler
2023 International Rome consensus for the nomenclature of Sjögren disease.
Nature reviews. Rheumatology · 2025 · 81 citations · Steven Carsons
Safety and Efficacy of Long-Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical Trial.
Arthritis & rheumatology (Hoboken, N.J.) · 2024 · 95 citations · Ellen Ginzler
Oral mucosal breaks trigger anti-citrullinated bacterial and human protein antibody responses in rheumatoid arthritis.
Science translational medicine · 2023 · 96 citations · Heidi Wong
Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes.
Annals of the rheumatic diseases · 2023 · 71 citations · Ellen Ginzler
American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 Joint Statement on Hydroxychloroquine Use With Respect to Retinal Toxicity.
Arthritis & rheumatology (Hoboken, N.J.) · 2021 · 95 citations ·
Phase III/IV, Randomized, Fifty-Two-Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus.
Arthritis & rheumatology (Hoboken, N.J.) · 2022 · 93 citations · Ellen Ginzler
Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Annals of the rheumatic diseases · 2022 · 81 citations · Ellen Ginzler